Bionano Genomics Inc reports results for the quarter ended in March - Earnings Summary

Bionano Genomics

10/05/2023 24:10

* Bionano Genomics Inc  BNGO.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 11 cents per share.
    * Revenue rose 30.2% to $7.42 million from a year ago;
analysts
expected $7.36 million. 
    * Bionano Genomics Inc's reported EPS for the quarter was a
loss
of 12 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Bionano Genomics Inc shares had fallen by 34.5% this
quarter and
lost 50.2% so far this year.
    * The company reported a quarterly loss of $37.12 million.
    * Wall Street's median 12-month price target for Bionano
Genomics
Inc is $5.40 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 11:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.11          -0.12          Missed
 Dec. 31 2022      -0.11          -0.13          Missed
 Sep. 30 2022      -0.11          -0.11          Met
 Jun. 30 2022      -0.09          -0.11          Missed